En
Français
Nederlands
Deutsch
Sleep apnoea in women: a chronically underdiagnosed condition
For decades, obstructive sleep apnoea (OSA) was regarded as predominantly a male condition. Yet recent epidemiological studies show that the actual male-to-female ratio is between 2:1 and 3:1 before the menopause - and approaches 1:1 after menopause. This massive underdiagnosis in women has direct consequences for cardiovascular health, mental health and everyday quality of life.
If you are a woman experiencing persistent fatigue, anxiety, morning headaches or treatment-resistant depression, this guide is for you. Sleep apnoea in women presents with symptoms that are often very different from those in men - and it is precisely this difference that makes it invisible to mainstream medicine.
Why is sleep apnoea underdiagnosed in women?
1. Atypical symptoms that go unrecognised
The classic picture of a sleep apnoea patient - an obese, snoring, daytime-sleepy man - does not match the female profile. Women with apnoea more often present with unexplained chronic fatigue, insomnia, frequent nocturnal awakenings, morning headaches, anxiety or depression resistant to treatment. These symptoms are frequently attributed to stress, menopause or psychiatric disorders, delaying diagnosis by years.
2. Snoring perceived as less severe
Female snoring is generally quieter than male snoring and therefore less often reported by bed partners. Yet snoring remains an important warning sign - even when subtle. Many women also feel embarrassed to mention this symptom to their doctor.
3. Screening tools calibrated on male profiles
Standard questionnaires used in general practice - the Berlin score and the STOP-BANG questionnaire - were developed and validated primarily on male populations. They give high weighting to loud snoring and daytime sleepiness, two symptoms less common in women. As a result, a woman with sleep apnoea can fall below the screening threshold even when she has moderate to severe disease.
4. Polysomnography less frequently prescribed
Studies show that doctors prescribe polysomnography (PSG) - the gold-standard diagnostic test - less often to women than to men presenting with comparable symptoms. This prescribing bias directly contributes to underdiagnosis in women.
Comparative table: sleep apnoea symptoms in women vs men
| Symptom | Women | Men |
|---|---|---|
| Loud snoring | Less frequent / quieter | Very common, loud |
| Excessive daytime sleepiness | Moderate, often masked | Marked, frequent |
| Chronic fatigue | Dominant symptom | Present but secondary |
| Insomnia / nocturnal awakenings | Frequent | Less frequent |
| Morning headaches | Frequent | Less frequent |
| Depression / anxiety | Often in the foreground | Secondary |
| Apnoeas observed by partner | Less often reported | Frequently reported |
| Nocturia (night-time voiding) | Frequent | Present |
Specific risk factors in women
Menopause: a major turning point
Menopause is by far the most important risk factor in women. The drop in oestrogen and progesterone levels - two hormones that protect pharyngeal muscle tone and regulate nocturnal breathing - multiplies the risk of apnoea by 2 to 3. This is why the incidence of apnoea in women increases sharply after age 50 and catches up with that of men of the same age. Hormone replacement therapy (HRT) appears to reduce this risk, but does not eliminate it.
Polycystic ovary syndrome (PCOS)
Women with PCOS have a risk of sleep apnoea 5 to 8 times higher than the general female population. The hyperandrogenaemia associated with PCOS alters the structure of the upper airway and promotes apnoea, independently of body mass index. If you have PCOS, screening for apnoea is strongly advised even in the absence of snoring.
Pregnancy
Gestational sleep apnoea affects approximately 8 to 27 % of pregnant women depending on the study. It is associated with an increased risk of pre-eclampsia, gestational diabetes and premature birth. Pregnant women who snore or wake up exhausted should mention this to their gynaecologist.
Hypothyroidism
Untreated hypothyroidism is a reversible cause of sleep apnoea: it reduces the muscle tone of the upper airway and causes myxoedematous infiltration of the tongue and pharynx. In any fatigued woman, TSH should be checked before - or alongside - a sleep assessment.
Cardiovascular impact: a risk often underestimated in women
Untreated sleep apnoea in women is associated with potentially more severe cardiovascular risk than in men. Several studies show that women with apnoea have a higher risk of arterial hypertension than men with apnoea at equivalent severity. The risk of stroke is also increased, particularly in post-menopausal women.
This difference is partly explained by the disappearance of the cardiovascular protective effects of oestrogens at menopause - leaving women with apnoea without this hormonal shield. It is therefore all the more urgent to diagnose and treat apnoea in women after menopause.
How to obtain a diagnosis
If you recognise yourself in the symptoms described, there are two diagnostic pathways:
Polysomnography in a sleep centre
This is the gold-standard examination. You sleep one night in a specialist centre where around twenty parameters are recorded: respiratory flow, thoracic effort, oxygen saturation, sleep stages, position, heart rate. It is the only test that can diagnose all types of apnoea, including central apnoea. For more on diagnostic testing, see our page home sleep apnoea test.
Home respiratory polygraphy
More accessible, this test records 4 to 7 respiratory parameters at home. It is sufficient to diagnose moderate to severe obstructive apnoea but may underestimate the AHI in women if apnoeas occur mainly during REM sleep (which is more common in women).
CPAP treatment in women: good news
Continuous positive airway pressure (CPAP) therapy is the gold-standard treatment for moderate to severe obstructive sleep apnoea - and women respond very well to it. Studies even show that therapeutic compliance is often better in women than in men, probably because women are more sensitive to chronic fatigue and perceive the benefit on their quality of life more quickly.
To optimise compliance, mask choice is crucial. Women generally have narrower faces and different facial structures. Three masks are particularly well suited:
- AirFit F40 (minimalist full-face mask): very compact design, clear field of vision, ideal for side sleepers. View the AirFit F40.
- AirFit P10 (nasal pillow mask): the lightest mask in the ResMed range, silent, perfect for women who do not want a mask over the nose. View the AirFit P10.
- Evora Full Face (Fisher & Paykel): clean design covering nose and mouth, minimal frame, highly rated by women with long hair. View the Evora Full Face.
Recommended CPAP devices for first-time users
| Device | Key features | Best for |
|---|---|---|
| ResMed AirSense 11 AutoSet | Auto-adjusting, myAir app, touchscreen, For Her algorithm | First treatment, easy daily monitoring |
| Philips DreamStation 2 | Compact, connected, intuitive interface | Bedside or travel, discreet profile |
| ResMed AirMini AutoSet | Ultra-light 300g, ideal for travel | Active women, frequent travel |
The AirSense 11 AutoSet is particularly noteworthy: it incorporates a "For Her" algorithm specifically designed to better detect apnoeas during REM sleep and female-predominant hypopnoeas - a clinically significant difference. For further guidance on managing your CPAP treatment, see our pages on CPAP side effects and optimal CPAP pressure settings.